2833 Smith Avenue
Suite 333
Baltimore, MD 21209
United States
443 738 4051
https://www.gcanrx.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 1
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Aitan Zacharin | Chairman, President, CEO, Acting CFO & Treasurer | 120k | N/A | 1983 |
Motti Stenge | Chief Operating Officer | N/A | N/A | N/A |
Dr. Adi Aran M.D. | Chief Scientific Advisor | N/A | N/A | N/A |
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The Greater Cannabis Company, Inc. was founded in 2014 and is based in Baltimore, Maryland.
El ISS Governance QualityScore de The Greater Cannabis Company, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.